Beijing VJTBio Co.
Latest round
- Series C
Last raised
- May 2023
Total raised
- $15M
Investors
- 10
About Beijing VJTBio Co.
, LTD. is a biotechnology company that engages in the R&D, production, and sales of new drugs for animals. It has a production base in Zhejiang, established in 2020, covering 30 mu, and equipped with two production factories. Dr Haoshu Luo, the company's president, engaged in the R&D of reproductive diseases and genetic engineering drugs and published more than 30 SCI papers., LTD., LTD. provides biological drugs for animal reproduction, pet diseases, and disease prevention and control. It established animal cell drug-expression technology platforms. It developed recombinant long-acting porcine follicle-stimulating hormone for pigs cattle, and sheep breeding. And it developed cytokine and subunit vaccine products for PEDV-induced diarrhoea in piglets. And it also provides a set of drug pilot production, quality control, and registration application industrial systems.
Who invested in Beijing VJTBio Co.
10 investors across 3 rounds
See all investors in Beijing VJTBio Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Beijing VJTBio Co.
Who invested in Beijing VJTBio Co.?
Beijing VJTBio Co. has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Beijing VJTBio Co. raised?
Beijing VJTBio Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Beijing VJTBio Co. last raise money?
Beijing VJTBio Co.'s most recent round on record is a Series C, in May 2023.
What does Beijing VJTBio Co. do?
Beijing VJTBio Co. is a biotechnology company.
Where is Beijing VJTBio Co. headquartered?
Beijing VJTBio Co. is headquartered in Beijing, China.
Which VCs invest in companies like Beijing VJTBio Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing VJTBio Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Beijing VJTBio Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.